Lifeward Ltd LFWD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $7.84
- Day Range
- $7.70–8.10
- 52-Week Range
- $4.14–10.56
- Bid/Ask
- $7.13 / $9.00
- Shares Outstanding
- 2.81M
- Market Cap
- $22.26M
- Volume/Avg
- 15,063 / 12,177
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.51
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 81
- Website
- https://www.golifeward.com
Valuation
|
Metric
|
LFWD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.49 |
Price/Sales | 0.51 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
LFWD
|
|---|---|
Quick Ratio | 1.64 |
Current Ratio | 2.40 |
Interest Coverage | −18.92 |
Quick Ratio
LFWD
Profitability
|
Metric
|
LFWD
|
|---|---|
Return on Assets (Normalized) | −49.07% |
Return on Equity (Normalized) | −108.61% |
Return on Invested Capital (Normalized) | −79.23% |
Return on Assets
LFWD
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|s@ttxy# | LOCK|>%>> | $175B | |||
| Stryker Corp
SYK
| LOCK|!Qy@!?YV | LOCK|Rg^ | $123B | |||
| Medtronic PLC
MDT
| LOCK|XRhlmv | LOCK|!YW@f | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|HbH#bg& | LOCK|rB>@ | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Smw%DC@> | LOCK|B$t? | $49B | |||
| DexCom Inc
DXCM
| LOCK|@RvCrXrW | LOCK|GjgQF | $30B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|j%ZH@!t | LOCK|@kH | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|%t# | LOCK|&gy | $26B | |||
| Steris PLC
STE
| LOCK|tBR@@l | LOCK|hxy>& | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|$wz#X?j | LOCK|^$T | $18B |
United States